BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33159179)

  • 1. Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.
    Sportoletti P; Sorcini D; Guzman AG; Reyes JM; Stella A; Marra A; Sartori S; Brunetti L; Rossi R; Papa BD; Adamo FM; Pianigiani G; Betti C; Scialdone A; Guarente V; Spinozzi G; Tini V; Martelli MP; Goodell MA; Falini B
    Leukemia; 2021 Jul; 35(7):1949-1963. PubMed ID: 33159179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
    Fagnan A; Bagger FO; Piqué-Borràs MR; Ignacimouttou C; Caulier A; Lopez CK; Robert E; Uzan B; Gelsi-Boyer V; Aid Z; Thirant C; Moll U; Tauchmann S; Kurtovic-Kozaric A; Maciejewski J; Dierks C; Spinelli O; Salmoiraghi S; Pabst T; Shimoda K; Deleuze V; Lapillonne H; Sweeney C; De Mas V; Leite B; Kadri Z; Malinge S; de Botton S; Micol JB; Kile B; Carmichael CL; Iacobucci I; Mullighan CG; Carroll M; Valent P; Bernard OA; Delabesse E; Vyas P; Birnbaum D; Anguita E; Garçon L; Soler E; Schwaller J; Mercher T
    Blood; 2020 Aug; 136(6):698-714. PubMed ID: 32350520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling and targeting of erythroleukemia by hematopoietic genome editing.
    Iacobucci I; Qu C; Varotto E; Janke LJ; Yang X; Seth A; Shelat A; Friske JD; Fukano R; Yu J; Freeman BB; Kennedy JA; Sperling AS; Zheng R; Wang Y; Jogiraju H; Dickerson KM; Payne-Turner D; Morris SM; Hollis ES; Ghosn N; Haggard GE; Lindsley RC; Ebert BL; Mullighan CG
    Blood; 2021 Mar; 137(12):1628-1640. PubMed ID: 33512458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Erythroid Leukemia: From Molecular Biology to Clinical Outcomes.
    Fernandes P; Waldron N; Chatzilygeroudi T; Naji NS; Karantanos T
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute erythroid leukemia.
    Zuo Z; Polski JM; Kasyan A; Medeiros LJ
    Arch Pathol Lab Med; 2010 Sep; 134(9):1261-70. PubMed ID: 20807044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype.
    Grossmann V; Tiacci E; Holmes AB; Kohlmann A; Martelli MP; Kern W; Spanhol-Rosseto A; Klein HU; Dugas M; Schindela S; Trifonov V; Schnittger S; Haferlach C; Bassan R; Wells VA; Spinelli O; Chan J; Rossi R; Baldoni S; De Carolis L; Goetze K; Serve H; Peceny R; Kreuzer KA; Oruzio D; Specchia G; Di Raimondo F; Fabbiano F; Sborgia M; Liso A; Farinelli L; Rambaldi A; Pasqualucci L; Rabadan R; Haferlach T; Falini B
    Blood; 2011 Dec; 118(23):6153-63. PubMed ID: 22012066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia.
    Meyer SE; Qin T; Muench DE; Masuda K; Venkatasubramanian M; Orr E; Suarez L; Gore SD; Delwel R; Paietta E; Tallman MS; Fernandez H; Melnick A; Le Beau MM; Kogan S; Salomonis N; Figueroa ME; Grimes HL
    Cancer Discov; 2016 May; 6(5):501-15. PubMed ID: 27016502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice.
    Di Genua C; Nerlov C
    Exp Hematol; 2021 May; 97():6-13. PubMed ID: 33600869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry (CyTOF).
    Maag AH; Swanton H; Kull M; Vegi NM; Feuring M
    Cytometry A; 2023 Jul; 103(7):551-562. PubMed ID: 36647792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
    Damm F; Chesnais V; Nagata Y; Yoshida K; Scourzic L; Okuno Y; Itzykson R; Sanada M; Shiraishi Y; Gelsi-Boyer V; Renneville A; Miyano S; Mori H; Shih LY; Park S; Dreyfus F; Guerci-Bresler A; Solary E; Rose C; Cheze S; Prébet T; Vey N; Legentil M; Duffourd Y; de Botton S; Preudhomme C; Birnbaum D; Bernard OA; Ogawa S; Fontenay M; Kosmider O
    Blood; 2013 Oct; 122(18):3169-77. PubMed ID: 24047651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dnmt3a deletion cooperates with the Flt3/ITD mutation to drive leukemogenesis in a murine model.
    Poitras JL; Heiser D; Li L; Nguyen B; Nagai K; Duffield AS; Gamper C; Small D
    Oncotarget; 2016 Oct; 7(43):69124-69135. PubMed ID: 27636998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ParaHox gene Cdx4 induces acute erythroid leukemia in mice.
    Thoene S; Mandal T; Vegi NM; Quintanilla-Martinez L; Rösler R; Wiese S; Metzeler KH; Herold T; Haferlach T; Döhner K; Döhner H; Schwarzmüller L; Klingmüller U; Buske C; Rawat VPS; Feuring-Buske M
    Blood Adv; 2019 Nov; 3(22):3729-3739. PubMed ID: 31770439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C/EBPα and GATA-2 Mutations Induce Bilineage Acute Erythroid Leukemia through Transformation of a Neomorphic Neutrophil-Erythroid Progenitor.
    Di Genua C; Valletta S; Buono M; Stoilova B; Sweeney C; Rodriguez-Meira A; Grover A; Drissen R; Meng Y; Beveridge R; Aboukhalil Z; Karamitros D; Belderbos ME; Bystrykh L; Thongjuea S; Vyas P; Nerlov C
    Cancer Cell; 2020 May; 37(5):690-704.e8. PubMed ID: 32330454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML.
    Garg S; Reyes-Palomares A; He L; Bergeron A; Lavallée VP; Lemieux S; Gendron P; Rohde C; Xia J; Jagdhane P; Müller-Tidow C; Lipka DB; Imren S; Humphries RK; Waskow C; Vick B; Jeremias I; Richard-Carpentier G; Hébert J; Sauvageau G; Zaugg JB; Barabé F; Pabst C
    Blood; 2019 Jul; 134(3):263-276. PubMed ID: 31076446
    [No Abstract]   [Full Text] [Related]  

  • 15. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation.
    Celik H; Mallaney C; Kothari A; Ostrander EL; Eultgen E; Martens A; Miller CA; Hundal J; Klco JM; Challen GA
    Blood; 2015 Jan; 125(4):619-28. PubMed ID: 25416276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
    Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
    Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification.
    Chen Y; Pourabdollah M; Atenafu EG; Tierens A; Schimmer A; Chang H
    Leuk Res; 2017 Oct; 61():39-43. PubMed ID: 28886412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stathmin 1 deficiency induces erythro-megakaryocytic defects leading to macrocytic anemia and thrombocythemia in Stathmin 1 knock out mice.
    Ramlogan-Steel CA; Steel JC; Fathallah H; Iancu-Rubin C; Atweh GF
    Blood Cells Mol Dis; 2021 Mar; 87():102522. PubMed ID: 33260083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis.
    Kelly MJ; So J; Rogers AJ; Gregory G; Li J; Zethoven M; Gearhart MD; Bardwell VJ; Johnstone RW; Vervoort SJ; Kats LM
    Nat Commun; 2019 Mar; 10(1):1347. PubMed ID: 30902969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.